TNFRSF17 and plasma cell myeloma: BCMA is essential for the proliferation and survival of plasma cells and is expressed at a much higher level in the surface of myeloma cells than in the case of other cell types, minimizing the off-target effect of BCMA targeting antibody–drug conjugates [8].